Persistence of the Use of Initially Prescribed Basal Insulin Therapies by People with Type 2 Diabetes (T2DM)

被引：0
|
作者：
Gordon, Jason P.
Mcewan, Phil
Home, Philip
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A148 / A149
页数：2
相关论文
共 50 条
  • [21] Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naive Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia
    Shafie, Asrul Akmal
    Ng, Chin Hui
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 333 - 343
  • [22] Looking for Predictors of Successful Basal Insulin Titration in T2DM
    Hermans, Michel P.
    Ahn, Sylvie A.
    Rousseau, Michel F.
    [J]. DIABETES, 2016, 65 : A252 - A252
  • [23] Stepwise Intensification of Prandial Insulin Versus Basal-Bolus Insulin Therapy in Patients (Pts) with Type 2 Diabetes Mellitus (T2DM)
    Raccah, Denis
    Haak, Thomas
    Huet, Dominique
    Monnier, Louis
    Penfornis, Alfred
    Robertson, Douglas
    Labard, Pascale
    Soler Ramon, Juan
    [J]. DIABETES, 2010, 59 : A151 - A151
  • [24] Choice of an Insulin Regimen at Insulin Initiation in People with Type 2 Diabetes Mellitus (T2DM)-Results from the CREDIT Epidemiological Study
    Freemantle, Nick
    Balkau, Beverley
    Danchin, Nicolas
    Genestin, Elisabeth
    Marre, Michel
    Vespasiani, Giacomo
    Kawamori, Ryuzo
    Home, Philip
    [J]. DIABETES, 2010, 59 : A177 - A177
  • [25] USE OF HEDIS A1C TARGETS IN CHARACTERIZING TREATMENT GOALS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INITIATING BASAL INSULIN
    Oster, G.
    Moen, D.
    Yang, T.
    Dalal, M.
    Kazemi, M.
    Sung, J. C.
    Traylor, L.
    Sullivan, S. D.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A70 - A70
  • [26] A Comparison of CV-FBG in T2DM with Use of Glargine/NPH as a Basal Insulin
    Mu Pan-Wei
    Zeng Long-Yi
    Zhang Guo-Chao
    Chen Yan-Ming
    Fu Jing-Yi
    Wang Man-Man
    [J]. DIABETES, 2010, 59 : A174 - A174
  • [27] Assessment of fitness in adolescents with type 2 diabetes (T2DM)
    Onyirimba, MN
    Moyna, NM
    Salomone, KA
    Cooper, DM
    Thompson, PD
    Estrada, DE
    [J]. DIABETES, 1999, 48 : A177 - A177
  • [28] Exenatide in insulin treated Type 2 diabetes (T2DM) patients: a potential next step
    Paisley, A. N.
    Wiles, P. G.
    [J]. DIABETIC MEDICINE, 2008, 25
  • [29] Use of sitagliptin in patients with type 2 diabetes (T2DM) and renal insufficiency (RI)
    Scott, Russell
    Hartley, Paul
    Luo, Edmund
    Yee, Jacqueline
    Davies, Michael
    Ferreira, Juan Camilo Arjona
    Williams-Herman, Debora
    [J]. DIABETES, 2006, 55 : A462 - A462
  • [30] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
12345